Spotlight: Stanford Psychiatry at the 2025 Annual Meeting of the Society of Biological Psychiatry

In late April, members of the Society of Biological Psychiatry (SOBP) gathered in Toronto, Canada, for the 2025 Annual Conference.

This is a special event for the Society as we celebrate a legacy of 80 years of excellence in biological psychiatry, and we discuss plans to shape the future of the field.

The theme of the conference was “Artificial Intelligence and Mental Health: A new landscape for research and practice.” The integration of AI in mental health research and practice is not just a promising frontier—it is swiftly evolving into a transformative force, offering tremendous potential while also presenting significant challenges.

Dr. Ira Glick received the 2025 Educator Award in Biological Psychiatry, which recognizes and honors the efforts of outstanding educators and their endeavors to promote and disseminate the understanding of biological psychiatry at the local, national or international levels. 

The conference featured dynamic array of keynote presentations, panel discussions, workshops, and poster sessions, all designed to foster collaboration and spark innovative ideas that can lead to meaningful advancements in the field. Several members of our department attended and presented at the meeting this year - explore their many topics in the list below.

Presentations

Generating Human Neural Diversity with a Multiplexed Morphogen Screen in Organoids
Oral Session I: ADHD, Autism, Neurodevelopmental Disorders, Depression & Suicide
Presenter: Kevin Kelley, M.D., Ph.D.

Ketamine Increases Theta Oscillations and Cortical Connectivity of the Human Hippocampus
Rising Star Oral Presentation
Presenter: Ethan Solomon, M.D., Ph.D.

Poster Sessions

Higher Intensity of Mystical Experience Following Magnesium-Ibogaine is Associated With Larger Decreases in PTSD Severity
Presenter: Randi Brown, Ph.D.

Insomnia Intervention Associated With Improvements in Affective Brain Function and Mood in Depression
Presenter: Adam Krause, Ph.D.

Evaluating Augmentation of Anti-Suicidal Effects of Intravenous Ketamine by Low Oral Doses of Opioid Receptor Partial Agonism
Presenter: Jason Tucciarone, M.D., Ph.D.

Transformer-Based Foundation Model for Functional Neuroimaging
Presenter: Teddy Akiki, M.D.

Disruptive High-Frequency Stimulation of the Limbic System Reduces Theta Band Activity in Relation to Baseline Connectivity
Presenter: Masataka Wada, M.D.

Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression
Presenter: Leanne Williams, Ph.D.

Effect of Cognitive Behavioral Therapy for Insomnia on Cognitive Functioning in Adults with Comorbid Insomnia and Depression
Presenter: Madeline Babros, B.S.

C4 Protein is Found in Neutrophils and Monocytes and May Be Altered in Individuals with Schizophrenia
Presenter: Agnieszka Kalinowski, M.D., Ph.D.

A Pilot Randomized Controlled Trial of Nitrous Oxide Inhalation in Unmedicated Adults with OCD: Proof of Concept
Presenter: Peter van Roessel, M.D., Ph.D.